| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
| 06/01/2011 | EP2326631A2 Mif modulators |
| 06/01/2011 | EP2326319A1 Conjugated suramin amino compounds for medical conditions |
| 06/01/2011 | CN102083853A Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 06/01/2011 | CN102083441A Use of nifurtimox for treating giardiasis |
| 06/01/2011 | CN102083440A Nifurtimox for treating diseases caused by trichomonadida |
| 06/01/2011 | CN102079783A Japanese blood fluke protein and application thereof |
| 06/01/2011 | CN102079782A Antibacterial peptide used for killing Cryptocaryon irritans and preparation method and applications thereof |
| 06/01/2011 | CN102079729A Compounds with antiparasitic activity and medicaments containing them |
| 06/01/2011 | CN102078549A Traditional Chinese medicine for treating oxyuriasis |
| 06/01/2011 | CN102078545A External pure Chinese traditional medicine preparation for treating scabies |
| 06/01/2011 | CN102078389A Application of extract of Chinese pulsatilla root to preparation of antischistosomal medicament, method for preparing extract of Chinese pulsatilla root and method for preparing preparation of extract of Chinese pulsatilla root |
| 06/01/2011 | CN102078313A High-efficiency, low-toxicity and safe plant source acaricidal medicament and preparation method thereof |
| 06/01/2011 | CN102077919A Feed additive for preventing and treating swine toxoplasmosis |
| 06/01/2011 | CN102077917A Feed additive for preventing and treating swine coccidiosis |
| 06/01/2011 | CN101536983B Albendazole oxide hydrochloride premix for animals |
| 06/01/2011 | CN101120659B Method for treating and preventing scuticociliatosis in fishes |
| 05/31/2011 | CA2480470C Inhibitors of nucleoside phosphorylases and nucleosidases |
| 05/27/2011 | CA2686584A1 Plasmodium proteases inhibitors and in silico screening methods for identifying the same |
| 05/26/2011 | WO2011063293A1 Boron-containing small molecules as antihelminth agents |
| 05/26/2011 | WO2011061848A1 Recombinant measles virus useful as bivalent vaccine against measles and malaria infection |
| 05/26/2011 | WO2011061747A1 Antifungal and anti parasitic conjugates of amphotericin b derivatives |
| 05/26/2011 | WO2011061277A1 Amino aryl acetamides and their use in the treatment of malaria |
| 05/26/2011 | WO2011061110A1 Fluorinated oxa or thia heteroarylalkylsulfide derivatives for combating invertebrate pests |
| 05/26/2011 | WO2011033115A3 Compounds useful against kinetoplastideae parasites |
| 05/26/2011 | WO2010051926A3 Halogen-substituted compounds used as pesticides |
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110124723 Compounds for Preventing and Treating Plasmodium Infections |
| 05/26/2011 | US20110124603 Trioxane Dimer Sulfur Compounds |
| 05/26/2011 | US20110123656 Fenugreek extract for treating human and animal diseases involving flagellate parasites |
| 05/26/2011 | US20110123631 Oral compositions of clindamycin |
| 05/26/2011 | US20110123556 Immunogen prioritization for vaccine design |
| 05/26/2011 | DE102009054265A1 Producing a gene encoded molecule comprises feeding a nucleic acid comprising a gene encoding the molecule to the arthropod |
| 05/26/2011 | CA2780955A1 Fluorinated oxa or thia heteroarylalkylsulfide derivatives for combating invertebrate pests |
| 05/26/2011 | CA2779563A1 Amidoacetonitrile compounds having pesticical activity |
| 05/25/2011 | EP2325196A1 Replikin peptides and uses thereof |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2323679A2 Clip inhibitors and methods of modulating immune function |
| 05/25/2011 | EP2114406B1 Thioxanthene derivates as sole anti-infective agents for use in the treatment of infectious diseases |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1349562B1 Inhibiting gs-fdh to modulate no bioactivity |
| 05/25/2011 | CN102071205A Specific antigen of clonorchis sinensis and application thereof |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070710A Specific GRA2a (Glycine Rich Antigen)-type antigenic protein of clonorchis sinensis and application thereof |
| 05/25/2011 | CN102070605A Imatinib mesylate polymorph and pharmaceutical composition |
| 05/25/2011 | CN102068679A Chinese medicament for treating porcine chronic trematodiasis |
| 05/25/2011 | CN102068462A Method for constructing eperythrozoon nude mice infection model |
| 05/25/2011 | CN102068461A Chinese medicinal composition for treating sores and erythra |
| 05/25/2011 | CN102068445A Method for preparing pulsatilla chinensis (Bunge) Regel saponin matter and application of pulsatilla chinensis (Bunge) Regel saponin matter in preparation of antischistosomal medicament |
| 05/25/2011 | CN102068444A Ointment for treating skin diseases |
| 05/25/2011 | CN101455729B Kangfulingshuan medicine production technique |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | CA2491701C Fredericamycin derivatives as drugs for tumor treatment |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 05/19/2011 | WO2011058210A1 Formulations of cationic lipoamino acids with lower haemolytic power based on the formation of catanionic pairs |
| 05/19/2011 | US20110118307 Compositions and methods for the treatment of infectious diseases |
| 05/19/2011 | US20110118212 Pestcidal active mixtures comprising isoxazoline compounds I |
| 05/19/2011 | US20110118196 Anti-phthiraptera treatment compositions |
| 05/19/2011 | US20110118176 Novel possibility of controlling diseases caused by trichomonadida |
| 05/19/2011 | US20110118175 Competitive inhibitors of invariant chain expression and/or ectopic clip binding |
| 05/19/2011 | US20110118122 Insecticidal pyridine compounds |
| 05/19/2011 | US20110118116 Azolin-2-ylamino Compounds for Combating Animal Pests |
| 05/19/2011 | US20110117187 Topical compositions and methods for epithelial-related conditions |
| 05/19/2011 | US20110117186 Intravenous infusion of curcumin and a calcium channel blocker |
| 05/19/2011 | US20110117184 Compositions for mucosal delivery of agents |
| 05/19/2011 | US20110117124 Enhancement of transgene expression from viral-based vaccine vectors by expression of suppressors of the type i interferon response |
| 05/19/2011 | US20110117120 Plasmodium falciparum HLA class I restricted T-cell epitopes |
| 05/19/2011 | US20110117107 Compositions and methods for diagnosis, prognosis and management of malaria |
| 05/19/2011 | US20110117014 Non-invasive diagnostic agents and methods of diagnosing infectious disease |
| 05/18/2011 | EP2322668A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms. |
| 05/18/2011 | EP2322667A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms. |
| 05/18/2011 | EP2322666A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms. |
| 05/18/2011 | EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy |
| 05/18/2011 | EP2322244A1 Pharmaceutical composition suitable for the treatment of malaria within one day |
| 05/18/2011 | EP2322210A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 05/18/2011 | EP2321295A2 4-(pyridin-4-yl)-1h-[1,3,5]triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases |
| 05/18/2011 | EP1467969B1 Dna minor groove binding compounds |
| 05/18/2011 | CN102058621A Artificial bear bile |
| 05/18/2011 | CN102058612A Compound emulsion for animals and preparation method thereof |
| 05/18/2011 | CN101102785B Prevention of vertical endoparasite infections |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/12/2011 | WO2011055083A2 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents |
| 05/12/2011 | WO2011054171A1 Tyrosine derivative histone deacetylases inhibitors and applications thereof |
| 05/12/2011 | WO2011054068A1 Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals |
| 05/12/2011 | US20110112054 Organophosphorous Compounds for the Activation of Gamma/Delta T Cells |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111398 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms |
| 05/12/2011 | US20110111058 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 05/12/2011 | US20110111056 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
| 05/12/2011 | US20110111015 Compositions and methods of enhancing immune responses to eimeria |
| 05/12/2011 | US20110110970 Chimeric vaccines |
| 05/12/2011 | US20110110961 Prolyl hydroxylase inhibitors |
| 05/12/2011 | DE102009053259A1 Use of hexosamine compounds and their analogs as pharmaceutical product, which inhibits the proliferation of trypanosomes, and thus for the treatment of trypanosome-induced disease |
| 05/12/2011 | CA2779720A1 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents |
| 05/12/2011 | CA2769996A1 Plasmodium falciparum sporozoite and liver stage antigens |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |